Alkemi helps pharmaceutical, biotech, and medtech companies:
.avif)
.avif)
With the right plan, challenges like evidence, value, and global access requirements become the drivers of successful launches and faster adoption. Here’s how Alkemi helps you turn obstacles into progress:
Differentiated value and credible economic evidence locked in before launch
Engaged stakeholders ready to advocate for adoption
Full cross-functional alignment so every team moves with one clear direction
Access frameworks built to scale seamlessly across global markets
Market access means showing value to every stakeholder, from payers to patient advocates. Alkemi’s solutions turn evidence into a story that secures adoption and access.
The strongest launches start years before approval. Launch Shield™ is Alkemi’s proactive market access system—designed to help you generate relevant evidence, prepare for payer/HTA requirements, anticipate competitive threats, and accelerate access readiness.
We identify early access risks, map payer and policy landscapes, pressure-test value arguments, and build pre-approved response playbooks for each scenario.
By the time you launch, your team is fully aligned and ready to respond to any payer challenge within days, not months.
Starting at
$150k
When access is under threat—pricing challenged, coverage restricted, or payer confidence shaken—every day counts. Our Access Threat Response System™ helps you regain control fast by pinpointing what changed, mapping the decision ecosystem, and rebuilding the case for coverage.
We mobilize quickly to validate payer requirements, pressure-test your value story, and deploy a decisive access response—preserving access, protecting uptake, and restoring momentum.
Starting at
$100k
With Alkemi, you get plans and tactics that result in positive decisions from payers, HTAs, guidelines and health systems. Each deliverable is designed to move your product closer to access and adoption.
Before launch, we build the foundation for patient access. We map the landscape, align teams, and prepare every moving piece needed for a confident launch.
Analyze treatment patterns, pricing benchmarks, and market dynamics to anticipate barriers and opportunities for access.
Structured interviews with payers, providers, thought leaders, patient advocates and more to reveal what each stakeholder needs to say yes.
Ensure clinical development and RWE programs capture the outcomes and endpoints HTA bodies and payers require for reimbursement decisions.
Identify what’s missing in your access story so gaps don’t become roadblocks during payer or formulary reviews.
.avif)
A practical roadmap for generating the access-focused evidence you’ll need across the product lifecycle.
Prepare submissions for national health services and HTA agencies across multiple countries, ensuring your strategy scales internationally.
Develop dossiers and payer tools that clearly demonstrate the economic and clinical value of your therapy.
Target the right stakeholders—payer panels, guideline committees, and key opinion leaders with coordinated engagement strategies.
Equip your market access and commercial teams with tools to communicate your value story consistently.
Simulate payer discussions to stress-test your value and pricing strategy to prepare field teams and affiliates for real-world challenges.
A structured framework and training tools for navigating the payer, policy, and formulary requirements that determine patient access across global markets.
Once your treatment is on the market, we help you adapt and defend your position so access grows, not fades.
Gather insights from payers, clinicians, and policy experts to refine the value proposition and update your market access strategy.
.avif)
Stay ahead of new entrants with strategies that counter competitor pricing, positioning, and value claims.
Continuously adapt your value story as new outcomes and payer expectations evolve.
Leverage real-world evidence to strengthen access arguments and demonstrate sustained value in practice.
Market access isn’t won with pricing alone. It takes clear strategies, stakeholder buy-in, and cross-functional execution that all point toward the same outcome: patients getting the treatments they need. Here’s how Alkemi helps you build access plans that deliver.
We break down silos so clinical, medical, commercial, and HEOR functions move forward with one coordinated launch plan.
Defensible frameworks built on economic value and health outcomes that convince payers, HTA bodies, and formulary decision makers.
Sharper insights into market value dynamics so your therapy stands out—even when new drugs and medical devices enter the field.
Plans tailored for national health services, HTA bodies, and price negotiation processes across multiple countries.
We engage patient advocates and healthcare professionals early to highlight unmet need, strengthen credibility, and accelerate adoption.
Every strategy we build connects back to the ultimate outcome: ensuring patients can actually receive, afford, and benefit from your therapy.
Go from kickoff to implementation in as little as 90 days instead of the 6-12 months the industry considers standard.
Most companies know they need a market access plan. Where they struggle is building one that payers, prescribers, patient advocates, and regulators all say yes to… and then actually implementing it.
That’s where Alkemi takes a different approach.
Rather than hand you a cookie-cutter strategy from a standard consulting playbook, we work alongside your team to provide direct, step-by-step support.
Every access strategy we design is tied to clear goals, grounded in relatable evidence, and shaped to resonate with the decision makers who matter most.
“Really appreciate your support - as you know I rang you in a bit of a panic a few weeks ago, yet the session came across as though you’d been working on it for months.”
![[headshot] image of customer (for a home inspector)](https://cdn.prod.website-files.com/68c86636bce64aae0bd583b2/68c86c5aee875a9e30534dab_da918c69-68ea-42eb-8ad0-fd4f176193a5.avif)
“When I presented the project output to our leadership, they said: 'You took a really scary situation and broke it down in terms we understand. It sounds like the team has a clear plan going forward'. That was my goal for this project so sounds like we achieved it.”
![image of successful businesses [headshot]](https://cdn.prod.website-files.com/68c86636bce64aae0bd583b2/68c86c59ad68004ea9ddd6b4_c1cd2a51-1f06-45cb-9a13-4199a77f0015.avif)
“In a record 3.5 days, guidelines have been updated to include [treatment]. Woohoo!!”
![[headshot]](https://cdn.prod.website-files.com/68c86636bce64aae0bd583b2/68c86c59dcf34a6442165770_122204b6-f407-479f-9bb7-84c323ad8f65.avif)
"[This report] is really great summary reflective of the session. Thank you to the team for leading this engaging session and distilling this important information for the team."
"Our team had a tight deadline for a key M&A decision. In just 2 weeks, Alkemi conducted a comprehensive review to synthesize the highest areas of opportunity illustrated by a heat map for our top 10 markets. Based on these robust insights, our program was greenlighted and we invited Alkemi back to share this wealth of information with across our broader business unit."
"Thanks to the whole team involved in staging this Advisory Council. I was fortunate to be able to attend and here the insights from the council members firsthand. The report provides an excellent summary."
"I really appreciate all the help from you during this project, I genuinely enjoyed working with you all and hope we can keep collaborating."
Market access isn’t about theory.
It’s about building and carrying out a plan that convinces payers, regulators, and advocacy groups with evidence they can relate to.
That’s why Alkemi works with you step by step.
If your plan isn’t actionable, we help you rework it until it is. The result is a strategy you can trust to expand patient access.
Alkemi helps you move from uncertainty to implementation. We’ll guide you step by step until your plan is ready for launch, and ready to win.